Biotin-PEG10-NHS ester , CAS No.B1445787

CAS: B1445787 Cat. No.: B1445787 Formula: C37H64N4O16S Peso molecolare: 852.99
Disponibile su ordine
Storage
Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
1mg
B1445787-1mg
Su ordinazione · 8–12 settimane
Enter a quantity for the sizes you want to add.

Panoramica

Biotin-PEG10-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Specifiche

Condizioni di conservazione di stoccaggio
Store at -20°C,Argon charged
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Nomi e identificatori
Peso molecolare
852.99

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

Note: The following protocols are general literature-guided examples for this reagent class. Optimize for your system. No item-specific validated protocols are provided in the Product Data.

A. Protein biotinylation (lysine-directed)

  • Prepare 10–20 mM stock of Biotin-PEG10-NHS ester in anhydrous DMSO under argon.
  • Exchange protein into PBS or HEPES, pH 7.5–8.0 (no amines). Typical concentration: 0.5–5 mg/mL.
  • Add reagent to achieve 5–10 molar eq relative to protein lysines (or 3–10 eq per protein), keeping DMSO ≤10% v/v. Incubate 1 h at RT with gentle mixing.
  • Quench with 50 mM Tris or 100 mM glycine for 15 min.
  • Purify by desalting column (e.g., 7 kDa MWCO spin) or dialysis. Determine DOL via HABA/Avidin assay or LC-MS.

B. Oligonucleotide biotinylation (amine-terminated oligo)

  • Dissolve oligo in 100 mM bicarbonate buffer, pH 8.3.
  • Add 10–20 mM DMSO stock to 5–20 eq relative to oligo. Incubate 1 h at RT.
  • Quench with 50 mM Tris. Purify by ethanol precipitation or spin desalting. Confirm by MALDI/ESI-MS.

C. Surface biotinylation (amine-functionalized glass/polymer)

  • Dry substrate thoroughly. Prepare 10–50 mM solution in dry DMF with 2–3 eq DIPEA.
  • Immerse substrate 1–2 h at RT. Rinse with DMF, then IPA, then water. Dry under nitrogen.
  • Block residual active sites with ethanolamine or BSA as appropriate. Validate with streptavidin binding assay.

General tips

  • Work quickly, minimize moisture, and prepare fresh aliquots. Keep solutions under inert gas (aligned with Product Data).
Biological Roles

Item-specific note

  • This product is for research use only (from Product Data). No medical or clinical use is claimed or intended.

Biotin background (literature/general)

  • Biotin (vitamin B7/H) is a bicyclic ureido-thiolane cofactor covalently attached to specific lysine residues of carboxylases via biotin ligase pathways. In metabolism, it serves as a CO2 carrier in carboxylation, decarboxylation, and transcarboxylation reactions.
  • Avidin/streptavidin interaction: Biotin binds with extraordinarily high affinity (Kd ~10^−14–10^−15 M, literature) to avidin family proteins. This interaction is the foundation for many capture, detection, and immobilization strategies in biochemical research.

Relevance of PEG10 spacer (literature/general)

  • Hydrophilicity and spacing: The PEG10 linker decreases nonspecific hydrophobic interactions and provides a flexible tether that can improve accessibility of biotin to streptavidin when conjugated to proteins, nucleic acids, or surfaces.
  • Reduced perturbation: Longer PEG linkers can mitigate steric shielding of epitopes and maintain biomolecule function compared to short-linker biotinylation reagents.

Important clarification

  • While the biotin moiety has well-known biological roles, Biotin-PEG10-NHS ester is a synthetic labeling reagent. Its function in the laboratory is to install biotin tags onto primary amines for downstream affinity interactions; it is not intended to modulate biological pathways or for therapeutic use.
Buffer Applications

Applicability: Highly relevant. NHS ester labeling efficiency and selectivity depend strongly on buffer composition and pH.

General buffer guidance for amine biotinylation (literature/general)

  • Recommended pH: 7.5–8.5 to deprotonate primary amines and promote acylation while managing competing hydrolysis.
  • Suitable buffers (avoid primary amines):
    • Phosphate-buffered saline (PBS), pH 7.4–7.8.
    • HEPES, pH 7.5–8.2.
    • Bicarbonate/carbonate, pH 8.3–8.5 (fastest reaction; increased hydrolysis risk).
    • MOPS at near-neutral pH when reduced reactivity is desired to limit over-labeling.
  • Avoid prior to quench: Tris, glycine, ethanolamine, and other primary/secondary amines; these will consume the NHS ester. These can be used intentionally after the reaction to quench residual activity.

Practical recipes (typical; literature/general)

  • PBS: 10 mM phosphate, 137 mM NaCl, 2.7 mM KCl, pH 7.4.
  • Bicarbonate: 100 mM NaHCO3/Na2CO3, pH 8.3–8.5.
  • HEPES: 50 mM HEPES, 150 mM NaCl, pH 7.8.

Operational tips

  • Prepare a fresh, concentrated stock of Biotin-PEG10-NHS ester in dry DMSO; add to the buffered target solution to ≤10% v/v organic. React 30–120 min at room temperature.
  • Include 1–5 mM EDTA if metal-catalyzed side reactions are a concern. Avoid high concentrations of competing nucleophiles (e.g., imidazole, high thiol levels) during the coupling step.
Green Alternatives

Context: NHS esters are inherently moisture-sensitive acylating agents; greener practice focuses on solvent choice, atom economy in workups, and minimizing excess reagent and hydrolysis byproducts.

Comparison of options (literature/general)

  • Current reagent: Biotin-PEG10-NHS ester
    • Pros: High reactivity with primary amines; PEG10 improves water compatibility and reduces nonspecific binding; enables low-organic content during bioconjugation.
    • Cons: Hydrolysis generates NHS waste; typically handled in DMSO/DMF (problematic on some green metrics).
  • Alternative activation chemistries:
    • Biotin-PEG10 TFP ester: 2,3,5,6-tetrafluorophenyl esters are often more hydrolytically stable than NHS, potentially lowering required excess and waste.
    • Biotin-PEG10 carbonate (pNP or pFP): May offer different hydrolysis/reactivity balance; selection depends on substrate sensitivity.
    • Enzymatic ligations (e.g., biotin ligase, sortase-mediated labeling): Aqueous, selective, minimal organic solvent; require enzyme and specific tag sequences.
  • Solvent considerations:
    • Favor anhydrous ethanol or ethyl acetate when feasible for small-molecule couplings; however, these are less ideal for proteins and may still promote hydrolysis.
    • Reduce DMSO/DMF volumes by using concentrated stocks (e.g., 10–50 mM) and immediate dilution into aqueous buffer.

Greener practice tips

  • Use stoichiometric control to minimize unreacted active ester.
  • Quench residual active ester with benign nucleophiles (glycine) before disposal.
  • Employ aqueous buffers and room temperature to reduce energy input; avoid halogenated solvents.
  • Consider solid-phase capture/cleanup to reduce solvent-intensive purifications.
Pharmaceutical Uses

Scope: No therapeutic claims. The following describes typical research and development roles for this reagent class.

Formulation and process roles (literature/general)

  • Affinity handles in analytical development: Installation of biotin-PEG10 tags on peptides, oligonucleotides, or proteins to facilitate streptavidin-based capture during purification, potency assays, or binding studies.
  • Conjugate intermediate in discovery: Biotin-PEG10-amine adducts are used as surrogates to probe target engagement and to enable pull-down/mass-spectrometry identification of binding partners.
  • Device/surface preparation: Biotinylation of amine-functionalized surfaces to assemble avidin-based capture layers for biosensors and microarrays under development.

Excipient status

  • This compound is not an excipient in pharmacopeias as supplied; it is an activated intermediate intended for conjugation chemistry. Any use in manufacturing or QC would be as a process reagent or analytical aid, followed by removal or quenching.

Regulatory considerations

  • For GMP contexts, verify identity, purity, residual solvents, and active ester content; establish incoming QC and storage controls (−20°C, inert atmosphere per Product Data). Risk-assess potential residual NHS and PEGylated byproducts; define validated removal steps (dialysis, ultrafiltration, or chromatography).

Note

  • For research use only (from Product Data). Suitability for clinical or diagnostic manufacture must be established separately; consult your QA/RA teams and relevant pharmacopeial guidance.
Physical Properties

Item-specific (from Product Data)

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Literature/general expectations for this compound class

  • Physical state: Typically an off-white to white solid or foam; hygroscopic and moisture-sensitive due to NHS ester hydrolysis (literature/general).
  • Solubility: Readily soluble in anhydrous polar aprotic solvents (DMSO, DMF, acetonitrile). PEG spacer confers partial solubility in aqueous buffers; however, NHS esters hydrolyze in water (literature/general). For aqueous labeling, dissolve in minimal dry DMSO then dilute into buffer immediately before use.
  • Partitioning: PEG10 markedly reduces hydrophobicity vs short-linker biotinylation reagents, improving aqueous compatibility and reducing nonspecific adsorption (literature/general).
  • pH stability: NHS esters are most stable at pH ≤6 and hydrolyze progressively at neutral to basic pH; amine-coupling is typically performed at pH 7.5–8.5 to balance reaction rate vs hydrolysis (literature/general).
  • Melting point, density, refractive index, logP: Not specified for this item; refer to CoA/Spec Sheet.

Practical notes

  • Prepare solutions immediately before use under dry conditions. Limit exposure to ambient humidity; hydrolysis yields the corresponding non-activated acid and reduces coupling efficiency.
  • Filter sterilization is generally unnecessary; if required, use low-binding PTFE or PVDF and minimize time in aqueous phase.
Quality and Grades

Item-specific (from Product Data)

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

General guidance on quality for NHS-activated PEG biotinylation reagents

  • Purity considerations: Effective conjugation relies on high content of intact NHS ester and minimal hydrolyzed acid. Typical quality documentation will report purity by HPLC and/or NMR and sometimes active-ester content by titration (literature/general). Absent item-specific values, consult the CoA for lot-specific assay.
  • PEG length definition: “PEG10” denotes a discrete oligomer with ten ethylene glycol units. Discrete-PEG reagents provide defined spacing and mass increments vs polydisperse mPEG. Verify polydispersity/index in the CoA when critical for mass-spec workflows (literature/general).
  • Stabilizers: These products are usually supplied without stabilizers to maintain reactivity; packaging under inert gas reduces adventitious hydrolysis. No stabilizer is specified for this item.
  • Analytics recommended in-use: Monitor conjugation efficiency by LC-MS (mass shift consistent with PEG10-biotin) or by HABA/avidin displacement assays. For small-molecule coupling, confirm conversion by LC-MS and disappearance of the amine starting material.
  • What the grade implies: When labeled as “bioconjugation grade” or “≥95%,” it typically indicates low residual solvents, low inorganic salts, and high active-ester content suited for protein labeling and surface chemistry. Since not specified here, verify suitability via small-scale trials.
Reaction and Applications

Scope (literature/general)

  • Primary purpose: Formation of stable amide bonds by acylation of primary amines (e.g., protein lysines, N-termini, surface-immobilized amines, and small-molecule amines). The biotin terminus enables high-affinity capture to (strept)avidin/NeutrAvidin systems for purification, visualization, immobilization, and assay assembly in research.
  • PEG10 spacer benefits: Increases hydrophilicity and spatial separation between biotin and the conjugated target, reducing steric hindrance and enhancing avidin accessibility, particularly on crowded protein surfaces or dense polymer brushes.

Representative applications

  • Protein/peptide labeling: Controlled biotinylation of antibodies, enzymes, and peptides under mild conditions; tuning of degree of labeling (DOL) by reagent-to-protein molar ratio and reaction time.
  • Surface modification: Biotinylation of amine-functionalized glass, silica, nanoparticles, hydrogels, and polymer films to build avidin-based capture layers.
  • Small-molecule derivatization: Installation of a biotin-PEG10 handle onto amine-bearing ligands for pull-down proteomics and affinity chromatography.
  • DNA/RNA conjugates: Biotinylation of amine-modified oligonucleotides for capture and detection.

Practical notes

  • Control hydrolysis: Add reagent last; use freshly prepared anhydrous stocks; keep reaction at pH 7.5–8.5 for biomolecules.
  • Quench/cleanup: After labeling, quench residual NHS ester with Tris or glycine; remove excess reagent and NHS by desalting, dialysis, or spin columns.
  • Verification: Determine DOL by HABA/Avidin assay, mass spectrometry, or absorbance-based methods if a chromophore is present on the target.
Reaction Conditions

General guidance (literature/general)

  • Protein/peptide labeling (aqueous):
    • Buffer: PBS, HEPES, or bicarbonate at pH 7.5–8.5 (avoid amine buffers until quench).
    • Stock: 10–50 mM in anhydrous DMSO or DMF.
    • Stoichiometry: 3–20 molar equivalents of NHS ester per protein (depending on desired DOL and lysine availability). For peptides/oligos, 1.2–3.0 eq is typical.
    • Temperature/time: 20–25°C for 30–120 min; gentle mixing. Ice bath can be used to limit over-labeling but slows kinetics.
    • Quench: 20–50 mM Tris or 50–100 mM glycine for 10–20 min; then desalt or dialyze.
  • Small-molecule/surface coupling (organic-rich):
    • Solvent: DMF or ACN; add 1.5–2.0 eq amine; 2–3 eq non-nucleophilic base (DIPEA) optional to accelerate.
    • Temperature: 20–40°C; typical times 0.5–4 h. Monitor by LC-MS or TLC (stain for PEG/biotin as needed).

Kinetic considerations

  • NHS hydrolysis half-life: On the order of tens of minutes to a few hours at pH 7.5–8.5 and RT (buffer-dependent). Add reagent last and avoid extended pre-incubation in aqueous buffers.
  • Salt and additives: Moderate ionic strength (100–200 mM NaCl) often benefits protein stability without strongly impacting acylation rate. Include EDTA to chelate trace metals if oxidation of the target is a concern.

Expected outcomes

  • Typical labeling degrees for proteins: 1–5 biotins/protein under mild conditions; broader ranges achievable with higher equivalents/time. Verify by HABA/avidin assay or mass spectrometry.
Safety and Handling

Item-specific (from Product Data)

  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word: Not specified for this item; refer to SDS.
  • H-statements and pictograms: Not specified for this item; refer to SDS.
  • Storage conditions: Store at -20°C, Argon charged (from Product Data). Shipped in ice chest with ice pads.

General safety guidance (literature/general)

  • Hazards: NHS esters are irritants; they acylate nucleophiles and can react with skin and eyes. Avoid contact and inhalation. PEGylated biotinylation reagents are not known to be volatile.
  • PPE: Lab coat, safety glasses, and nitrile gloves. Use in a chemical fume hood when handling powders or preparing stock solutions. Change gloves frequently to avoid breakthrough and hydrolysis contamination.
  • Incompatibilities: Water, alcohols, primary/secondary amines, strong bases; these accelerate hydrolysis or consume the active ester. Avoid prolonged exposure to buffer at pH >8 prior to addition to the amine target.
  • First aid (overview; defer to SDS):
    • Skin/eye contact: Immediately flush with water for ≥15 min; remove contaminated clothing; seek medical attention if irritation persists.
    • Inhalation: Move to fresh air; seek medical attention if symptoms occur.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.
  • Waste: Collect unused solutions and rinses as halogen-free organic waste or aqueous reactive waste per institutional guidelines. Quench residual NHS ester with glycine or ethanolamine before drain disposal policies are considered; follow local regulations.
Solvent Selection

Relevance: This reagent is moisture-sensitive and typically handled in dry organic solvents; aqueous buffers are used only transiently during amine coupling.

General solvent guidance (literature/general)

  • Primary solvents for stock solutions: Anhydrous DMSO or DMF. These dissolve PEGylated biotin efficiently while preserving the NHS ester.
  • Cosolvents/diluents at reaction: For biomolecule labeling, add the DMSO/DMF stock into pH 7.5–8.5 aqueous buffer (≤10% organic v/v) immediately prior to use. For surface/solid-phase or small-molecule amine coupling, neat DMF or ACN with a non-nucleophilic base (e.g., DIPEA) is common.
  • Avoid: Protic solvents (water, methanol, ethanol) during stock preparation; amine-containing buffers (Tris, glycine) prior to the intended coupling; high-basicity media that accelerate hydrolysis.
  • Polarity and miscibility: PEG10 confers high polarity; solutions in DMSO/DMF are miscible with water, enabling homogeneous reaction mixtures upon dilution.

Comparison notes (literature/general)

  • Versus short-linker NHS-biotin: PEG10 offers improved aqueous compatibility and reduced nonspecific protein binding.
  • Versus sulfo-NHS biotinylation reagents: Sulfo-NHS variants are directly water-soluble but can be more prone to hydrolysis; PEG10-NHS in DMSO stocks offers controlled delivery into buffer with comparable kinetics.

Practical tips

  • Use dry, oxygen-impermeable vials; purge headspace with argon (aligned with Product Data). Prepare single-use aliquots to avoid repeated moisture exposure.
Storage and Reconstitution

Item-specific (from Product Data)

  • Storage conditions: Store at -20°C, Argon charged.
  • Shipping: Ice chest with ice pads.
  • Research use note: For research use only.

General best practices (literature/general)

  • Packaging: Keep in original, tightly sealed, moisture-barrier container. If re-aliquoting, use dry, argon- or nitrogen-purged vials to preserve NHS activity.
  • Desiccation: Store with desiccant; avoid frost-free freezers that cycle humidity. Allow container to warm to room temperature before opening to prevent condensation.
  • Reconstitution: Prepare concentrated stocks (e.g., 10–50 mM) in anhydrous DMSO or DMF immediately before use. Filter through 0.2 µm PTFE if particulate is present, minimizing air exposure.
  • Aliquoting: Divide into single-use aliquots; refreezing partially used aliquots risks moisture uptake and hydrolysis.
  • Working solution stability: In dry DMSO/DMF, hours to days at RT depending on dryness; in aqueous buffers, the NHS ester hydrolyzes within minutes to hours at pH 7.5–8.5. Prepare only what is needed for the experiment.
  • Freeze–thaw: Avoid repeated freeze–thaw cycles. If necessary, limit to ≤2 cycles and verify activity by a small-scale test coupling.
  • Disposal: Quench unused material with glycine or ethanolamine before disposal. Follow institutional and local regulations for organic reactive waste.
Structure and Identity

Item-specific (from Product Data)

  • Product name: Biotin-PEG10-NHS ester (SKU: B1445787)
  • CAS: B1445787 (catalog identifier)
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

General structural description (literature/general)

  • Structural class: Heterobifunctional bioconjugation reagent composed of a biotin moiety and an N-hydroxysuccinimide (NHS) activated ester separated by a discrete poly(ethylene glycol) spacer with 10 ethylene glycol repeat units (PEG10).
  • Functional groups: Ureido-imidazolidone fused to a tetrahydrothiophene ring (biotin core), ether linkages along PEG chain, terminal activated carboxylate as an NHS ester (succinimide ring attached via an acyl linkage).
  • 2D description in words: A bicyclic biotin ring system on one end is linked through a flexible -(CH2CH2O)10- PEG chain to a terminal carbonyl that is activated as an O-succinimidyl ester; the succinimide is a five-membered imide ring enabling rapid acyl transfer to nucleophilic primary amines.
  • Reactivity handle: The NHS ester selectively acylates primary amines (–NH2) to form stable amide bonds, releasing N-hydroxysuccinimide as the leaving group.
  • Stereochemistry: The biotin core bears the native stereocenters found in D-biotin; the PEG segment is achiral; the NHS ring is achiral.
Synthetic Utility

Reagent function (literature/general)

  • Electrophile for amide bond formation: The NHS ester activates the terminal carboxylate, enabling rapid acylation of primary amines under mild conditions to form robust amide linkages. The leaving group is N-hydroxysuccinimide.
  • Spacer engineering: PEG10 provides defined spacing to mitigate steric hindrance and improve solubility of the resulting conjugate; useful in constructing affinity probes, linkers, and surface modifiers.

Applications in synthesis and materials

  • Small-molecule derivatization: Install a biotin-PEG10 handle onto amine-bearing scaffolds to create affinity capture probes for target ID or PROTAC-related tool compounds (as non-therapeutic research probes).
  • Polymer and surface functionalization: Reaction with amine-functionalized polymers (e.g., polylysine, PEI, PAAm derivatives) and aminated oxides forms biotinylated materials for hierarchical assembly with avidin/streptavidin.
  • Oligo/protein modification: Convert amine-terminated oligonucleotides and lysine residues into biotinylated conjugates under aqueous, room-temperature conditions.

Strategic considerations

  • Site-selectivity: Control via pH, stoichiometry, and time; for proteins, lysines with higher pKa and solvent exposure react preferentially. For N-terminal selectivity, use near-neutral pH and shorter reaction times.
  • Orthogonality: NHS ester is generally orthogonal to azide/alkyne click handles, maleimides (thiols), and aldehyde/oxime ligations, enabling sequential conjugation strategies.
  • Analysis: Track conversion by LC-MS (mass shift equals biotin-PEG10), HPLC UV/ELSD, or avidin-based capture efficiency.
Target Specificity

Item-specific data

  • Target specificity, antigen/epitope, clone, isotype, and species reactivity: Not applicable to this small-molecule labeling reagent. No antibody or biologic targeting information is provided for this item.

General clarification (literature/general)

  • Chemical selectivity is driven by functional group reactivity. The NHS ester reacts broadly with accessible primary amines (e.g., lysine side chains, N-termini, surface amines). Specificity at the molecular level is controlled by reaction conditions, substrate accessibility, and stoichiometry rather than by biological recognition.
  • Downstream binding specificity derives from the biotin–(strept)avidin interaction, which is strong and well-characterized, but this is an affinity interaction, not an intrinsic target specificity of the reagent itself.

Domande frequenti

How should this product be stored?
Store at ?20 °C under argon. It is supplied under an argon blanket; reseal under inert gas after each use.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is B1445787, the molecular formula is C37H64N4O16S, and the molecular weight is 852.99 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.